Cold & Cough Remedies (Pharmacies) - Kyrgyzstan

  • Kyrgyzstan
  • Revenue in the Cold & Cough Remedies market is projected to reach US$2.38m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 4.88%, resulting in a market volume of US$3.02m by 2029.
  • In global comparison, most revenue will be generated in China (US$7,826.00m in 2024).
  • In relation to total population figures, per person revenues of US$0.35 are generated in 2024.

Key regions: Canada, United Kingdom, United States, China, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Cold & Cough Remedies (Pharmacies) market in Kyrgyzstan is experiencing significant growth due to changing customer preferences, emerging trends, and local special circumstances.

Customer preferences:
Customers in Kyrgyzstan are increasingly seeking over-the-counter cold and cough remedies from pharmacies. This shift in preference can be attributed to the convenience and accessibility of pharmacies, as well as the rising awareness of self-care and the importance of early treatment for cold and cough symptoms. Additionally, customers are becoming more inclined towards natural and herbal remedies, driving the demand for products with natural ingredients.

Trends in the market:
One of the key trends in the Cold & Cough Remedies (Pharmacies) market in Kyrgyzstan is the increasing demand for combination products. Customers are looking for remedies that provide relief from multiple symptoms, such as congestion, cough, and sore throat, in a single product. This trend is driven by the need for convenience and cost-effectiveness, as well as the desire to minimize the number of products consumed. Another trend in the market is the growing popularity of preventive remedies. Customers are becoming more proactive in managing their health and are seeking products that can boost their immune system and prevent cold and cough symptoms. This trend is fueled by the increasing emphasis on wellness and preventive healthcare, as well as the desire to reduce the frequency and severity of cold and cough episodes.

Local special circumstances:
Kyrgyzstan has a harsh climate with long and cold winters, which makes the population more susceptible to cold and cough infections. This creates a higher demand for cold and cough remedies, as people seek relief from symptoms and strive to recover quickly. Additionally, the country has a high prevalence of smoking, which can exacerbate cold and cough symptoms and drive the need for remedies to alleviate respiratory issues.

Underlying macroeconomic factors:
The growing middle class in Kyrgyzstan, coupled with increasing disposable incomes, is driving the demand for Cold & Cough Remedies (Pharmacies). As people have more financial resources, they are more willing to spend on healthcare and wellness products, including over-the-counter remedies. Furthermore, the expanding healthcare infrastructure and the growing number of pharmacies in the country are making these products more accessible to the population. In conclusion, the Cold & Cough Remedies (Pharmacies) market in Kyrgyzstan is witnessing growth due to changing customer preferences, emerging trends, local special circumstances, and underlying macroeconomic factors. The demand for over-the-counter remedies from pharmacies is driven by convenience, the rising awareness of self-care, and the need for early treatment. Combination products and preventive remedies are gaining popularity among customers. The harsh climate and high smoking prevalence in Kyrgyzstan contribute to the demand for cold and cough remedies. The growing middle class, increasing disposable incomes, and expanding healthcare infrastructure are also fueling the market growth.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)